ArticleInternational urogynecology journal2021
Timing of recurrence after surgery in pelvic organ prolapse.
Article in International urogynecology journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Prolapse recurrence, methods of reoperation, and long-term mesh complications-A nationwide follow-up study.Acta obstetricia et gynecologica Scandinavica · 2026Article
- Long-Term Effectiveness and Safety of Laparoscopic Uterosacral Ligament Suspension with Hysterectomy for Pelvic Organ Prolapse: A Prospective Cohort Study with Over 7 Years of Follow-Up.International journal of women's health · 2026Article
- Impact of levator ani muscle avulsions on Manchester procedure outcomes: A 5-year follow-up study.Acta obstetricia et gynecologica Scandinavica · 2025Article
- Extreme Uterine and Rectal Prolapse in a 31-Year-Old Patient: A Case Report.Journal of clinical medicine · 2025Article
- [Subtotal vaginal hysterectomy with cervical ring preservation and cervical stump suspension to the sacrospinous ligament in women with pelvic organ prolapse: An exposed cohort study].Revista colombiana de obstetricia y ginecologia · 2024Article
- Identification of potential molecular mechanisms and therapeutic targets for recurrent pelvic organ prolapse.Heliyon · 2023Article
Corrections and comments
- Commented on by
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe aim of this study was to determine when women are at risk for recurrent pelvic organ prolapse (POP).
methodsFrom 2010 to 2018, all women with symptomatic prolapse, Pelvic Organ Prolapse Quantification (pop-Q) stage 2 in at least one compartment and prolapse surgery were included. The primary outcome measure was POP recurrence. Kaplan-Meier estimates were calculated, survival curves were created, and differences in survival curves were tested with log-rank test. Cox proportional hazard regression was used to investigate associations between recurrence and the number and type of involved compartment(s) and type of surgery.
resultsForty-six (16.8%) out of 274 patients had POP recurrence during a mean follow-up time of 55 ± 32 months. The mean age was 64 ± 12 years. The hazard of recurrence increased the most in the first 2 years after POP surgery, flattened in years 3 and 4 and remained almost stable in the years thereafter, regardless of the site and number of involved compartment(s). The hazard of recurrence over time seemed the largest when all three compartments were involved. However, there was no statistically significant difference in recurrence between the numbers of (p = 0.65) or in the combination of involved compartments (p = 0.19). There was no difference in POP recurrence over time between prolapse repair with either sacrospinous ligament fixation or vaginal hysterectomy (p = 0.48).
conclusionsWomen are at the highest risk of POP recurrence in the first 2 years after POP surgery independent of the number or combination of involved compartment(s).
Indexed as
Identifiers
33730233What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.